Search

A patent has been issued to Liberty Commercial Imports & Exports Services LLC for a contact lens designed to treat various ocular disorders, including high cylinder astigmatism. The contact lens aims to reshape the cornea by causing migration of epithelial cells and applying a staining feature to treat astigmatism effectively. This innovation addresses the limitations of traditional contact lenses used in orthokeratology, offering a potential solution for patients with different types of astigmatism and other eye conditions. [Extracted from the article]

A patent application titled "Atropine Pharmaceutical Compositions" by inventors from New Jersey has been published online by Vyluma Inc. The application focuses on creating stable, low-dose ophthalmic atropine compositions with a physiologically acceptable pH and minimal preservatives. These compositions aim to address stability issues and reduce side effects associated with current atropine formulations used in pediatric studies for myopia treatment. The patent application outlines specific formulations and methods to achieve these goals. [Extracted from the article]

SightGlass Vision Inc. has been issued a patent for ophthalmic lenses with dynamic optical properties aimed at reducing the development of myopia. The patent describes how the eye lens focuses light onto the retina and the impact of eye-length-related disorders like myopia. The invention features an ophthalmic lens with optically-switchable components that can partially scatter or defocus light, potentially offering a solution to myopia. [Extracted from the article]

A patent has been issued for actively adaptive optical apparatuses designed to reduce myopia development, particularly in children. The patent, filed by Pixieray Oy in Finland, aims to address the limitations of conventional optical apparatuses by incorporating active optical elements that adjust optical powers based on the user's gaze direction and depth perception. This innovative technology seeks to provide a more effective solution for myopia control and prevention. [Extracted from the article]

A recent study presented at a medical conference in China suggests that living in flats or apartments may be associated with an increased risk of myopia in young children. The study found that the prevalence of myopia has increased in a predominantly Caucasian population following the COVID-19 pandemic, possibly due to prolonged periods of home-confinement and increased use of electronic devices. Myopia, or short-sightedness, can lead to complications if left untreated. The findings of this study align with previous research conducted in England, indicating a global increase in myopia rates. [Extracted from the article]

A patent application by Digiteyez Corporation titled "Virtual Eye Disease Progression Monitoring and Diagnostics" has been made available online. The patent application describes a system and method for diagnosing eye diseases and providing a platform for eye specialists to communicate with patients, particularly pediatric patients. The system includes a story-led monthly eye test that can be accessed through personal devices, allowing patients to take tests in an engaging and reliable manner. The test results are sent to eye care specialists who can track disease progression and schedule appointments with patients. The system also includes interfaces for testing visual acuity, contrast detection, and astigmatism. Overall, the system aims to provide accurate and seamless eye disease diagnosis and monitoring. [Extracted from the article]

A patent has been issued for a video display system that provides vision correction for multiple users without the need for glasses or contact lenses. The system uses various technologies, such as LCDs, polarizers, and spatial light modulators, to create a holographic effect that adjusts based on the viewer's angle of view. It also includes a camera to detect the user's identity and viewing angle. The goal of this technology is to allow multiple users with different vision correction needs to view a shared video image without the need for individual eyewear. [Extracted from the article]

A patent application has been filed for a progressive spectacle lens that aims to reduce the progression of myopia in children. The lens is designed to correct ocular aberrations and provide clear vision at different distances. It consists of different viewing zones with varying refracting power, including a central zone for distance vision, lower and upper zones for near vision, and two peripheral zones to correct peripheral hyperopic shift. The lens is made from a polymeric material and can be customized based on the wearer's needs. The patent application also includes claims for different variations of the lens and methods for designing and manufacturing it. [Extracted from the article]

A new report discusses research findings on myopia, specifically focusing on axial elongation in children with low to moderate myopia. The study conducted a meta-regression analysis using data from 64 studies and found that Asian children have a 38% greater rate of axial elongation compared to non-Asians. However, both groups show a 15% decline in axial elongation per year as age increases. The study emphasizes the challenge of managing individual children due to the large range of individual axial elongation rates in the population. The analysis is limited by the use of aggregated data rather than individual subject data. [Extracted from the article]

A recent study conducted by Johnson & Johnson examined the effectiveness of myopia control interventions. The study found that the terms "responders" and "non-responders" may not accurately distinguish between different groups of individuals. The research showed that individuals with faster or slower progression of myopia achieved similar benefits from treatment. This challenges the common belief that some individuals respond better to interventions than others. The study was a robustly designed, placebo-controlled trial and received financial support from Johnson & Johnson USA. [Extracted from the article]

A patent has been issued to Acucela Inc. for an apparatus designed to treat refractive error using active stimulation. The invention aims to slow or stop the progression of myopia by providing stimuli that are defocused in front of or behind the retina. The apparatus consists of projection modules and optical elements that generate and direct light to form a stimulus image in the desired location of the eye. This technology can be incorporated into spectacles, contact lenses, virtual or augmented reality devices, smartphones, and other similar devices. [Extracted from the article]

The patent application titled "Progressive Spectacle Lens" by inventors Jester, Spratt, and Varnas proposes a new type of lens to improve the treatment of myopia in children. The lens is designed to reduce lag of accommodation and hyperopic defocus on the peripheral retina, with clear distance vision in the central zone and clear near vision in the lower peripheral zone. The inventors suggest that these lenses can help slow down the progression of myopia. The full patent provides more information on the background and details of the invention, including the design and manufacturing process. [Extracted from the article]

A patent has been issued for a device and method to modify the axial length and curvature of an eye. The invention aims to improve vision and refractive power by restoring the natural curvature and length of the eye. The device consists of a plate, an anchor, and a body, all with concave scleral mating surfaces. The implant is designed to be smaller than the natural axial length of the eye. Myopia, or near-sightedness, is a common condition that affects a significant portion of the global population, and this invention offers a potential solution to address its impact on visual impairment and quality of life. [Extracted from the article]

Johnson & Johnson Vision Care Inc. has been issued a patent for a comfort-optimized contact lens system for non-rotationally symmetric eye aberrations. The system includes contact lenses with different levels of stabilization to correct vision and optimize comfort. The lenses have a thickness differential between the stabilization zone and the non-stabilization zone. This system provides a cost-effective and efficient way to optimize comfort for patients in need of vision correction. [Extracted from the article]

A patent has been issued for devices, systems, and methods aimed at controlling myopia, or short-sightedness. The patent describes techniques using ophthalmic lenses and optical elements to slow the progression of myopia or limit its occurrence. These techniques involve modifying the optical signal received by the cones in the retina, particularly the M and L cones, through the use of conflicting chromatic cues. The patent also includes specifications for the design of the lenses, such as the spacing and shape of micro lenslets. For more information, refer to the full patent. [Extracted from the article]

Eyebright Medical Technology (Beijing) Ltd, the first domestic manufacturer of high-end refractive intraocular lenses in China, has reported strong financial results for the first half of 2024. The company saw a 68.54% increase in total operating revenue and a 27.49% increase in net profit compared to the same period last year. Eyebright Medical focuses on surgical treatment, myopia management, and consumer vision care, offering a range of ophthalmic solutions. The company's commitment to innovation is reflected in its substantial investment in research and development, as well as the expansion of its R&D team. [Extracted from the article]

A patent has been issued for a contact lens with selective wavelength transmittance. The lens is designed to address vision conditions such as myopia and hyperopia. It includes a filtering characteristic that blocks light with wavelengths between 400 and 500 nanometers, while transmitting light with wavelengths above 500 nanometers. The lens is made of a polymer material and incorporates a blocking agent to achieve the desired filtering characteristic. The patent also describes methods for making the contact lens. The assignee for this patent is Menicon Singapore Pte Ltd. [Extracted from the article]

The article highlights the patent application number 20240252835 for a "Device For Projecting Images On The Retina," filed by Hans Bernhard and colleagues on April 11, 2024. It also discusses the device's potential to stimulate retinal changes, the limitations of existing myopia treatments, and various technical aspects of the proposed solution.

The article highlights the patent application number 12050368 for anti-myopia-progression spectacles and associated methods, filed by Barry Jonathan Linder and Yan Zhou on April 7, 2023, and published online on July 30, 2024. It also discusses the design of spectacles aimed at reducing myopia progression, the use of micro-reticles and lenses for optimal image focus on the retina, and improvements over existing anti-myopia spectacles.

A patent has been issued to Bausch & Lomb Ireland Limited for an ophthalmic lens designed to address myopia, a condition that causes blurred vision when objects at a distance are focused in front of the retina. The lens includes a peripheral zone with an add-power offset and a spatially-modulated optical parameter, which aims to suppress the progression of myopia. The invention seeks to provide efficacy in reducing myopia progression while minimizing visual disturbances such as glare and halos. The lens is designed to be larger than the wearer's pupil diameter and may have a central zone diameter of at least 3 mm. [Extracted from the article]

A patent has been issued for a lens designed for myopic eyes or eyes at risk of myopia. The lens includes a distance viewing zone with a central region for clear distance vision and peripheral regions with positive power to correct for peripheral refractive errors. It also has a lower near viewing zone with a central region that accounts for accommodative lag. The lens is intended to prevent myopia or slow its progression. The patent was filed by Brien Holden Vision Institute Limited. [Extracted from the article]

A patent has been issued to Essilor International for a lens element designed to slow down the progression of abnormal refractions of the eye, such as myopia or hyperopia. The lens element includes a holographic recording medium that can convert an interference pattern into a holographic optical element. The method for manufacturing the lens element involves obtaining wearer prescription data and recording a holographic optical element within the holographic recording medium to provide an additional optical power of opposite sign to the prescribed optical power. This invention aims to address focusing defects and potentially reduce the progression of myopia in individuals, particularly children. [Extracted from the article]

A patent application has been submitted for a "Functional Layer Application System" by inventors Craig Drury, James Kunkel, and David Olund. The patent application aims to efficiently add functional layers, such as photochromic or polarized layers, to lenses for treating myopia and inhibiting ametropia. The lens may consist of microlenses or lenslets with different refraction forces, and the functional layer can provide additional utility, such as photochromic functionality or polarization. The application describes various methods and techniques for fabricating lenses with functional layers, including injection molding and specific temperature and pressure parameters. The patent application was filed on December 4, 2023, and made available online on June 6, 2024. The assignee of the patent is HOYA Optical Labs of America Inc. [Extracted from the article]

Carl Zeiss Vision International GmbH has been issued a patent for a progressive spectacle lens that aims to reduce the progression of myopia. The lens design includes different viewing zones for distance and near vision, as well as peripheral vision. The patent provides detailed descriptions of the lens design and its potential benefits. The article also discusses the impact of myopia on eye health, particularly in relation to technology use, and mentions the involvement of optical and technology companies in addressing this issue. The information presented is based on research and discoveries from various sources. [Extracted from the article]

A patent application has been submitted by inventors from Essilor International for a new type of eyewear that aims to address the issue of myopia control. The eyewear includes a light adjusting means that modifies the original image into a modified image, providing an increased amount of positive contrast signal for the user's retina. The modification is achieved through a light intensity pattern adjustment, which can be produced by a transmission pattern or a light emission pattern on the lenses of the eyewear. The invention aims to provide an improved solution for myopia control that does not require lifelong use of corrective lenses. [Extracted from the article]

Acucela Inc. has been granted a patent for a device that can project images onto the retina of the eye. This device is designed to stimulate the retina and promote changes in the axial length and choroidal thickness of the eye. It can project both still and dynamic images with a refresh rate ranging from 1 Hz to 500 Hz. The device can be integrated into various devices such as projectors, ophthalmic equipment, TV screens, computer screens, handheld devices, wearable devices, and intraocular lenses. The patent describes the use of micro-lens arrays to collect and focus light from micro-displays, creating images that can be placed on different regions of the retina. The device can also provide refractive correction and generate images with specific shapes and angles. The patent also mentions other components and features of the device, including light sources, projection optics, and sensors. [Extracted from the article]

Study after study has concluded that leadership development programs aren't effective. Experts suggest that the problem revolves around how companies implement leadership development programs--for example, too much classroom training, poor [...]

A patent has been issued to Reopia Optics Inc. for systems and methods to retard the progression of myopia. The invention involves the use of simulated sunlight to illuminate the eyes and prevent myopia progression. Myopia, also known as near or short-sightedness, is increasing globally, particularly in Asia. Exposure to outdoor sunlight has been shown to reduce myopic progression, but current interventions are inadequate. The patented system includes a computerized device with a display screen, an ambient light source, an illumination sensor, and a processor to dynamically adjust the illumination to target specific wavelength bands or luminance for retarding myopia progression. [Extracted from the article]

A patent application has been submitted by Bausch + Lomb Ireland Limited for an ophthalmic lens that aims to suppress the progression of myopia. The lens includes a peripheral zone with an add-power offset and a spatially-modulated optical parameter. The invention addresses the issue of some wearers not achieving the desired suppression of myopia progression with conventional lenses, as well as the potential vision disturbances caused by stray light passing through the peripheral zone. The lens is designed to provide efficacy in reducing myopia progression while minimizing visual disturbances. [Extracted from the article]

A patent has been issued for a laser eye surgery system calibration. The patent describes improved methods and systems for treating materials such as tissue, specifically for cutting tissue during eye surgery to treat conditions like cataracts and refractive errors. The invention involves mapping laser beam focus locations and generating a treatment table to adjust the laser beam pulse energy at specific target locations in the eye. The goal is to improve the accuracy of the cutting process and reduce complications. The patent was filed by AMO Development LLC and published online on April 23, 2024. [Extracted from the article]

A study conducted at a surgical center in Draper, Utah compared changes in the posterior curvature and the posterior-anterior radii ratio of the cornea one year after laser eye surgeries for myopia. The study included 199 eyes from 119 patients who underwent laser in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), or small incision lenticule extraction (SMILE). The researchers found that the change in the posterior-anterior radii ratio did not differ between the surgery groups, and the posterior cornea exhibited flattening after LASIK, SMILE, and PRK. The study provides valuable information for individuals considering these surgical treatments for myopia. [Extracted from the article]

A patent has been issued for an apparatus and methods for controlling axial growth with an ocular lens. The patent, filed by inventor Stephen D. Newman, describes an ocular lens that can help reduce or eliminate myopia and hyperopia by controlling the growth of the eye's axial length. The lens includes isolated positive optic features that direct peripheral light away from the central region of the retina, creating a controlled defocus effect. The lens can be a contact lens, soft contact lens, rigid gas permeable contact lens, or implantable lens. The patent was assigned to Menicon Singapore Pte Ltd. [Extracted from the article]

This document discusses a recently issued patent for ophthalmic compositions and methods of use. It emphasizes the importance of the microenvironment in cellular differentiation and the development of therapeutics using stem cell technologies. The structure and function of the cornea are explained, along with conditions such as myopia and keratoconus. The document highlights the need for permanent treatments for these conditions and the challenges in understanding their underlying biochemical processes. It also mentions the high prevalence of keratoconus in New Zealand, particularly among Pasifika and Maori populations. The patent describes new compositions and methods for modulating corneal cells to regenerate and augment the cornea, offering non-invasive therapies for corneal thinning and irregularities. The patent claims a kit that includes a composition containing a TGFb3 polypeptide and dexamethasone, as well as contact lenses or other devices, for treating or preventing refractive errors and corneal conditions without causing scarring. [Extracted from the article]

A patent has been issued for a myopia control lens and related methods. The lens is designed to control the progression of myopia by dividing it into regions with different lens powers. The patent describes a lens with a spiral power map, where the spirals on the inner and outer surfaces twist in opposing directions. This design aims to provide a more stable ratio of lens powers and reduce variations in the ratio of myopic defocus to distance vision as the wearer's pupil dilates and constricts. The lens can be used in contact lenses or spectacle lenses. [Extracted from the article]

A patent has been issued to Optica Amuka (A.A.) Ltd. for the control of dynamic lenses. The patent describes an optical device that uses an electro-optical layer to adjust the refractive index of the lens, allowing for the modification of focal properties. The device includes an array of excitation electrodes and control circuitry to generate a specified phase modulation profile. The patent also mentions the use of a polarization rotator to ensure that the light incident on the lens has a component of the desired polarization. This invention has potential applications in vision correction, particularly for myopia. [Extracted from the article]

A patent has been issued to NovaSight Ltd. for a method and device that can treat and prevent refractive errors, as well as process and display images. The invention focuses on ophthalmology and aims to achieve emmetropia, which is the match between the power of the eye's optics and its axial length. The patent describes methods and devices that can improve image quality for central vision while intentionally degrading image quality for non-central vision. This technology has potential applications in the treatment and prevention of refractive errors, particularly myopia. [Extracted from the article]

A patent has been issued to Acucela Inc. for a device that predicts, diagnoses, plans, and monitors myopia. Myopia, also known as near-sightedness, is a visual disorder that worsens over time. The device measures refractive properties of the eye at different locations, including the central retina and the peripheral retina, to provide a more accurate diagnosis and treatment. The device uses light sources, projection optics, imaging optics, an imaging device, and a processor to capture and analyze images of the eye. This invention aims to improve the measurement and treatment of refractive errors in myopia. [Extracted from the article]

A patent has been issued for an ophthalmic composition developed by Sydnexis Inc. The composition contains a muscarinic antagonist, such as atropine or atropine sulfate, and deuterated water. It also includes a buffering agent to maintain a specific pH level. The composition is intended for the treatment of pre-myopia, myopia, or the progression of myopia. The patent provides detailed information about the formulation and concentration of the components in the composition. [Extracted from the article]